
Myocardial Protection With Phosphocreatine in High-Risk Cardiac Surgery Patients: A Randomized Trial
This study was conducted to test the hypothesis that phosphocreatine (PCr), administered intravenously and as cardioplegia adjuvant in patients undergoing cardiac surgery with prolonged

